The largest database of trusted experimental protocols

P65 inhibitor bay11 7802

Manufactured by Merck Group
Sourced in United States, Germany

P65 inhibitor (BAY11-7802) is a chemical compound that functions as an inhibitor of the NF-kappa-B essential modulator (NEMO), a regulatory subunit of the IKK complex. This compound can be used in research applications to study the role of the NF-kappa-B signaling pathway in various biological processes.

Automatically generated - may contain errors

2 protocols using p65 inhibitor bay11 7802

1

Signaling Pathway Antibody Validation

Check if the same lab product or an alternative is used in the 5 most similar protocols
RARα (sc-773), MEK1/2 (sc-436), NF-κB-p65 (sc-109), IκB-α (sc-1643), p62 (sc-28359) and actin (sc-47778) antibodies were obtained from Santa Cruz Biotechnology (TX, USA); The antibodies to CD11b (C0551) and ICAM-1 (C2969) were from Sigma(St. Louis, MO, USA); Antibody to LC3 (#NB600-1384) was from Novus (Littleton, CO, USA); The p-ERK1/2 (#9101), ERK1/2 (#4695), p-JNK (#9251), JNK (#9252), p-P38 (#9215), P38 (#9212) and PCNA (#2586) antibodies were from Cell Signaling Technology (MA, USA); ATRA, ATO, DMSO, JNK inhibitor (SP600125), p38 inhibitor (SB203580) and ERK inhibitor (U0126) were from Cell Signaling Technology (MA, USA); p65 inhibitor (BAY11-7802) was from Merck Millipore (Darmstadt, Germany); The recombinant HMGB1 protein was kindly provided by Dr. Rui Kang (University of Pittsburgh, USA).
+ Open protocol
+ Expand
2

NB4 Cell Line Differentiation with ATRA

Check if the same lab product or an alternative is used in the 5 most similar protocols
APL cell line NB4 was generously provided by Prof. Tong Jian-hua (Shanghai Ruijin Hematology Institute, China), which originated from Dr. M. Lanotte, INSERM Unit 301, St. Louis Hospital (Paris) [15] (link). This cell line was established from a patient with APL, who harbors characteristic chromosome abnormality, i.e., t(15∶17), and responds to ATRA with granulocytic differentiation. NB4 cells were seeded at a density of 5×105 cells/mL and maintained in RPMI-1640 culture medium supplemented with 10% fetal calf serum, 2 mM of L-glutamine, 100 U/ml penicillin, and 100 µg/ml streptomycin stored at 37°C in a 5% CO2 humidified atmosphere.
For experimentation, NB4 cells were plated at 2×105 cells/ml in complete RPMI- 1640 medium and pre-treated with celastrol or protein inhibitors for 30 min, and then incubated in the presence of ATRA (1 µmol/L) for the indicated times. ATRA at 1 µM was used to induce NB4 maturation to granulocytes. P38 inhibitor SB203580, JNK inhibitor SP5600125, and MEK inhibitor U0126 were purchased from Cell Signaling Technology (Danvers, MA, USA). P65 inhibitor BAY11-7802, ERK inhibitor FR180204, and STAT1 inhibitor AG490 were purchased from Merck Millipore (Calbiochem, Darmstadt, Germany).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!